Glucose-Lowering Medications Reduce CV Risk in Hispanic Patients With Diabetes
Hispanic patients with type 2 diabetes who receive SGLT2 inhibitors have decreased risk for major adverse cardiovascular events.
Stay updated with breaking news from Controlled Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hispanic patients with type 2 diabetes who receive SGLT2 inhibitors have decreased risk for major adverse cardiovascular events.
Lidocaine patches can help with postoperative pain and reduce the need for opioids when used in combination with other pain relief methods.
The US Preventive Services Task Force said more research is needed before lipid screenings can be conducted among children with clear benefit.
Hispanic patients with type 2 diabetes who receive SGLT2 inhibitors have decreased risk for major adverse cardiovascular events.
Semaglutide and phentermine/topiramate use resulted in the greatest amount of weight loss and waist circumference reduction in patients with obesity.